欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号IE/H/0113/001
药品名称Botulinum Toxin 100 Type A Allergan
活性成分
    • Clostridium botulinum type A neurotoxin complex (900 kD) 0.0 [no unit]
剂型Powder for solution for injection
上市许可持有人Allergan Pharmaceuticals Ireland, Castlebar Road Westport County Mayo Ireland
参考成员国 - 产品名称Ireland (IE)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • Iceland (IS)
    • Austria (AT)
      BOTOX 100 Allergan-Einheiten Pulver zur Herstellung einer Injektionslösung
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Latvia (LV)
      Botox 100 Allergan vienības pulveris injekciju šķīduma pagatavošanai
    • Lithuania (LT)
      BOTOX 100 Allergan vienetų milteliai injekciniam tirpalui
    • Estonia (EE)
      BOTOX
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Slovenia (SI)
    • Malta (MT)
    • Croatia (HR)
    • France (FR)
    • Poland (PL)
    • Bulgaria (BG)
    • Romania (RO)
许可日期2000/04/26
最近更新日期2024/12/23
药物ATC编码
    • M03AX01 botulinum toxin
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Full Dossier Article 4.8 Di 65/65
  • TypeLevel4:Biological: Other
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase